Kiniksa Pharmaceuticals International Plc (KNSA)
58.60
+1.67
(+2.93%)
USD |
NASDAQ |
May 08, 16:00
58.54
-0.06
(-0.10%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Total Liabilities (Quarterly) : 219.59M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 156.37M |
| Amgen, Inc. | 83.31B |
| Savara, Inc. | 50.30M |
| BioMarin Pharmaceutical, Inc. | 2.379B |
| United Therapeutics Corp. | 813.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 825.28M |
| Shareholders Equity (Quarterly) | 605.69M |
| Debt to Equity Ratio | 0.0149 |
| Current Ratio | 3.794 |
| Net Debt Paydown Yield | 0.00% |